Metabolic dysfunction-associated steatohepatitis (MASH) significantly increases the risk of liver cirrhosis and ...

Wu Tiangen, a 31-year-old surgeon from China, lost 25 kg in just 42 days, inspiring both his patients and the public.

Fatty liver disease is often misunderstood and underrated. Many people think that if they don’t have any symptoms, they don’t need to worry. But this belief can be dangerous. Let’s bust this myth and ...

Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) Formerly known as nonalcoholic fatty liver disease (NALFD) MASLD occurs when fat builds up to more than 5 to 10 percent of your ...

An enlarged liver may also be seen with congestive heart failure or cancer, among other conditions. Alcoholic or nonalcoholic fatty liver disease Fatty liver disease happens when the organ begins ...

developed a simplified scoring system to identify the presence of FIP. The scoring system is based on the presence of obesity, hyperlipidemia, and fatty liver, each of which is assigned a score of 1, ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...

The performance of AAV gene-therapy vectors is studied in machine-perfused human livers — and the presence of fatty liver disease makes a difference.

Diet For Fatty Liver Disease: The liver plays a crucial role in maintaining the body's overall health by metabolizing nutrients, filtering toxins, and producing bile to aid digestion. However ...

Google is ringing in the Lunar New Year with a nostalgic twist. To celebrate the Year of the Snake, the search engine has launched an animated Google Doodle that features a modern take on the classic ...

Google is ready to celebrate with an appropriately snake-ified Doodle. In addition to the main Lunar New Year Doodle, Google’s also got a special edition for South Korea. With February creeping ...

Akero Therapeutics reported Monday strong results from a nearly two-year, placebo-controlled study showing its drug efruxifermin reversed liver scarring in patients with cirrhosis caused by the ...